QuotedData on F&C’s 150th birthday, plus our monthly roundup featured in DIY investor magazine. The granddaddy of the investment trust sector, Foreign & Colonial Investment Trust, is rapidly approaching its 150th birthday. It is a remarkable achievement for a company to remain relevant over such a long period. What, perhaps is even more remarkable is […]
Worldwide Healthcare rejigs portfolio, adds BMS, Vertex stakes OrbiMed-managed Worldwide Healthcare Trust (WWH) has added new large shareholdings in Bristol-Myers Squibb and Vertex to its portfolio, displacing holdings in Intuitive Surgical and Cigna from its top 10, according to the trust’s latest factsheet. The changes follow the addition of a holding in Merck & Co in January, and […]
Polar Capital swaps Merck for Lilly – Polar Capital Global Healthcare (PCGH) acquired a large holding, representing ~3% of its NAV, in US pharmaceutical giant Lilly in January, at the same time selling its entire holding in Merck & Co, according to an analysis by Marten & Co. Lilly appears in 14th position by size as […]
AEW UK REIT buys Dagenham leisure park – AEW UK REIT has acquired the eastern section of London East Leisure Park, Cook Road, Dagenham and an industrial unit let to Plastipak UK Limited on Gresford Industrial Estate, Wrexham for a combined price of GBP22.5m. Dagenham Leisure Park London East Leisure Park is a purpose built leisure […]
BlackRock Emerging Europe offers 100% tender – BlackRock Emerging Europe has been out-performing its benchmark, by 5.7% in US dollar terms in the year to 31 January 2018. The NAV increased by 35.5% in US Dollar terms (19.9% in sterling terms) which compared favourably with the benchmark (MSCI Emerging Europe 10-40 Index) return of 29.8% in […]
John Laing Infrastructure propose moving domicile to UK – The NAV of John Laing Infrastructure [JLIF] rose by 9.5% the company informed shareholders in its final report for the year ending 31 December 2018. The share price, however, fell by 4.8%. The value of the portfolio value rose by 13.3% to £1,379.3 million, with the underlying portfolio growing by […]
Profits growth and falling discount mean a good year for F&C Private Equity shareholders – in its final report for the year to 31st December 2017, F&C Private Equity (FPEO), the chairman commented that the portfolio continued to make progress during the year. Profits growth and falling discount Over the year, the NAV returned 5.6% (on a total […]
Highcroft’s property income grows 22% in 2017 – Highcroft Investments (HCFT) delivered its final report for the calendar year ending 31 December 2017. Headlines: 22.0% increase in gross property income, which is the strongest performance over the last 5 years 16.8% increase in investment property valuation Property acquisitions of £9,480,000 (net of costs) and disposal […]
Menhaden made some money in 2017 – Menhaden’s NAV total return for the year ended 31 December 2017 was +7.8% (2016: +1.8%) and the share price total return was +3.2% (2016: -13.8%). The MSCI World Total Return Index (in sterling) increased by 11.8% (2016: +28.2%). By way of additional comparison, the WilderHill New Energy Global Innovation Index […]
IBT takes profits on Nektar, buys Array SV Health-managed International Biotech Trust (IBT) saw a 2.2% fall in NAV in February, beating the 2.6% decline reported for the sterling-adjusted value of the benchmark Nasdaq biotechnology index by a small margin, one of only a handful of sector specialist trusts to do so. The main positive […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
